PD
MIRM icon

Point72 (DIFC)’s Mirum Pharmaceuticals MIRM Stock Holding History

Point72 (DIFC)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$198K Buy
+2,702
New +$172K 0.01% 446
2025
Q2 		– Sell
-3,283
Closed -$148K – 1900
2025
Q1 		$148K Sell
3,283
-1,077
-25% -$50.8K 0.01% 975
2024
Q4 		$180K Buy
+4,360
New +$182K 0.01% 892
2024
Q2 		– Sell
-2,721
Closed -$68.4K – 1739
2024
Q1 		$68.4K Buy
+2,721
New +$74.8K ﹤0.01% 1151

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Point72 (DIFC)'s MIRM Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2025: 2,702 shares worth $198K. The stake represents 0.01% of the portfolio and ranks #446 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in MIRM as recently as Q1 2025.

Point72 (DIFC) first reported a position in MIRM in Q1 2024 and has held it in 4 quarters since. 272 funds tracked by Wall St. Rank hold MIRM as of Q3 2025.

  • Point72 (DIFC) held 2,702 shares of Mirum Pharmaceuticals worth $198K as of Q3 2025.
  • Mirum Pharmaceuticals was a new Point72 (DIFC) position in Q3 2025.
  • Mirum Pharmaceuticals made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #446 holding.
  • Point72 (DIFC) first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 4 quarters since.
  • 272 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.